Doctor profile · Federal record

Dr. Scott McShane, DO

Internal Medicine Physician (CMS: Internal Medicine) · Gastroenterology Physician · Spokane, WA

  • NPI 1629330394
  • Accepts Medicare
  • MIPS 77.2 / 100 · 2023
  • 14 yrs in practice
  • Licensed in 2 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
105 W 8Th Ave Ste 6010
Spokane, WA 992042318
(509) 838-5950
fax (602) 839-2084

Credentials & registration

NPPES · NUCC
NPI registered
June 2012 — 14 yrs on file
Profile last updated
August 14, 2023
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
207R00000X — NUCC code
State licenses (2)
Arizona #R2118 · Washington #OP60908904

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1629330394. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,698
Distinct HCPCS
10
Medicare allowed
$136,899
HCPCS Description Services Patients Avg allowed
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,240 15 $33
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 97 93 $101
45380 Biopsy of large bowel using a flexible endoscope 97 96 $154
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 79 79 $240
96413 Administration of chemotherapy into vein, 1 hour or less 35 16 $133
82947 Blood glucose (sugar) level 30 30 $4
99214 Established patient office or other outpatient visit, 30-39 minutes 26 24 $127
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope 24 23 $144
96415 Administration of chemotherapy into vein, each additional hour 24 13 $28
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 21 21 $162

In context: peer comparison

Among 80 peers in Spokane Internal Medicine Physician, average services per provider: 106. This provider delivers 25× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$992
Transactions
47
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 16 $344.07
Lilly USA, LLC 7 $162.26
Regeneron Healthcare Solutions, INC. 7 $144.25
Takeda Pharmaceuticals U.S.A., INC. 4 $84.67
Intercept Pharmaceuticals, INC. 3 $45.78
Janssen Biotech, INC. 1 $32.54
Salix Pharmaceuticals, A Division of Bausch Health US, LLC 1 $32.10
Pfizer INC. 2 $30.59
Genzyme Corporation 1 $24.11
Celgene Corporation 1 $22.32
Fresenius Kabi USA, LLC 1 $20.41
Ferring Pharmaceuticals INC. 1 $18.65
Braintree Laboratories, INC. 1 $14.97
Ardelyx, INC. 1 $14.78

By nature of payment

Food and Beverage
$992

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
748
Patients
452
Total drug cost
$447,341
Drug Type Claims Patients Total cost
Gavilyte-C (Peg3350/Sod Sulf,Bicarb,Cl/Kcl) Brand 227 226 $4,280
Omeprazole Generic 200 87 $3,450
Mesalamine Generic 55 13 $35,242
Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,Mag Sulfates) Brand 52 51 $3,883
Pantoprazole Sodium Generic 39 15 $713
Ondansetron Odt (Ondansetron) Brand 38 30 $352
Gavilyte-G (Peg3350/Sod Sulf,Bicarb,Cl/Kcl) Brand 31 30 $523
Diphenoxylate-Atropine (Diphenoxylate Hcl/Atropine) Brand 18 0 $770
Dicyclomine Hcl Generic 17 0 $355
Famotidine Generic 17 0 $216

Frequently asked questions

Auto-generated from federal data
What is Dr. Scott McShane's medical specialty?
Dr. Scott McShane practices Internal Medicine Physician in Spokane, WA.
Where does Dr. Scott McShane practice?
Dr. Scott McShane practices at 105 W 8Th Ave Ste 6010, Spokane, WA 992042318. Office phone: 5098385950.
What is Dr. Scott McShane's NPI?
Dr. Scott McShane's National Provider Identifier (NPI) is 1629330394, issued by NPPES.
Does Dr. Scott McShane accept Medicare assignment?
Yes. Dr. Scott McShane accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Scott McShane commonly perform?
Top Medicare-reported procedures in 2023: Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope (HCPCS 43239); Biopsy of large bowel using a flexible endoscope (HCPCS 45380). Source: CMS Medicare Physician & Other Practitioners file.